Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics
This study will evaluate the benefit of lidocaine perfusion in cancer related visceral pain resistant to morphinics. It is an efficacy study in adults and children and a randomized prospective study.
Cancer|Pain
DRUG: Lidocaine
To determine prospectively the lidocaine efficacy in 2 types of patient populations with cancer (group A: children from 6 to 14 years old and group B: adults from 15 to 70 years old), continuous intravenous perfusion for 6 days
To confirm the tolerance of the lidocaine
This study will evaluate the benefit of lidocaine perfusion in cancer related visceral pain resistant to morphinics. It is an efficacy study in adults and children and a randomized prospective study.